Cryogenic OGS Files Half-Yearly Fund Utilization Deviation Statement

Cryogenic OGS Ltd has submitted its Statement of Deviation or Variation in Utilization of Funds for the half-year ended September 30, 2026, as per SEBI LODR Regulations. The statement, reviewed by the audit committee and the Board of Directors on October 29, 2026, indicates no specific deviations or variations in the utilization of funds raised from its Initial Public Offer. The funds were originally allocated for working capital requirements, general corporate purposes, and issue-related expenses. The company has also made the statement available on its website.